Amyloid formation as a protein phase transition
Alongside GLP-1 RAs, the DPP-4 inhibitors have been developed to exploit the incretin system by prolonging the duration of endogenous GLP-1 (Nauck and Meier, 2016)
Glioblastoma: defining tumor niches
Meanwhile, individual coverage topped $9,300, on average, this year, up 5% with employees shouldering $1,440 of the cost and employers paying the rest
Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages
The Phase 2 Trial: NCT07437547 In February 2026, Hudson Biotech began recruiting participants for the first properly designed randomized controlled trial of BPC-157 in humans